| Symbol |
Name |
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM2
|
adrenomedullin 2
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ANXA2
|
annexin A2
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CDH13
|
cadherin 13
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CREG1
|
cellular repressor of E1A-stimulated genes 1
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL6
|
chemokine (C-X-C motif) ligand 6
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
F11
|
coagulation factor XI
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FBLN7
|
fibulin 7
|
|
FGF16
|
fibroblast growth factor 16
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GP6
|
glycoprotein VI (platelet)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
ITGAV
|
integrin, alpha V
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
KDR
|
kinase insert domain receptor
|
|
KITLG
|
KIT ligand
|
|
KNDC1
|
kinase non-catalytic C-lobe domain (KIND) containing 1
|
|
KNG1
|
kininogen 1
|
|
KRT15
|
keratin 15, type I
|
|
LEP
|
leptin
|
|
LTB4R
|
leukotriene B4 receptor
|
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3)
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MIR155
|
microRNA 155
|
|
MIR29A
|
microRNA 29a
|
|
MIR92A1
|
microRNA 92a-1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP10
|
matrix metallopeptidase 10
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOX1
|
NADPH oxidase 1
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
|
P2RX6
|
purinergic receptor P2X, ligand gated ion channel, 6
|
|
PARG
|
poly (ADP-ribose) glycohydrolase
|
|
PGF
|
placental growth factor
|
|
PHPT1
|
phosphohistidine phosphatase 1
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PRG4
|
proteoglycan 4
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROCR
|
protein C receptor, endothelial
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RCAN3
|
RCAN family member 3
|
|
RHOA
|
ras homolog family member A
|
|
SELE
|
selectin E
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SMAD2
|
SMAD family member 2
|
|
ST8SIA2
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2
|
|
ST8SIA4
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM1
|
transglutaminase 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
USMG5
|
up-regulated during skeletal muscle growth 5 homolog (mouse)
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VWF
|
von Willebrand factor
|